Skip to main content
Figure 2 | Arthritis Research & Therapy

Figure 2

From: Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial

Figure 2

Effectiveness outcomes over time with standard deviations. (a) Disease Activity Score in 28 joints (DAS28). (b) Health Assessment Questionnaire Disability Index (HAQ-DI). (c) EQ-5D. (d) 36-item Short-Form Health Survey (SF-36). PCS, Physical Component Summary. Month 0 represents the start of the treatment.

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us